Searched for
LAURUS LABS NEWS
Laurus Labs shares climb 4% after Q2 profit zooms 126% YoYLaurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-ye...- Shukra Medtech, Laurus Labs among 4 healthcare stocks to hit 52-week highs and rally up to 26% in a monthThe Sensex surged 905 points to close at 74,151, while four healthcare stocks hit fresh 52-week highs. Shukra Medtech, Acutaas Chemicals, P...
- JioBlackRock Flexi Cap Fund exits Eternal, Ashok Leyland and 16 more, trims stake in RIL, HDFC Bank and 32 othersJioBlackRock Flexi Cap Fund made complete exits from 18 stocks, including Eternal and Ashok Leyland, in September 2026, while trimming stak...
- 8 midcap stocks rally up to 135% in a year; 2 turn multibaggersEight midcap stocks have gained 50%-135% over the past year, outperforming the broader market. Laurus Labs and Apar Industries more than do...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities reversed morning gains on Tuesday, with Sensex falling 330 points and Nifty closing lower after sharp volatility during the...
- Tata Sons listing to improve SP Group bond outlook; yields seen tighteningShapoorji Pallonji bond yields are expected to tighten significantly after the RBI rejected Tata Sons' application. The Reserve Bank of Ind...
- 11 stocks that recorded profit margins above 10% for 4 straight quarters; surge up to 120%
- F&O Radar | Laurus Labs signals strong bullish trend; how to play the upsideLaurus Labs shares are surging, hitting a new all-time high near Rs 1,128.50. Analysts see strong bullish momentum, with the stock trading ...
- Laurus Labs shares tumble 4% despite 886% surge in Q2 PAT. Should you buy the dip?Laurus Labs shares fell despite Q2FY26 PAT surging 886% to Rs 195 crore, revenue rising 35%, and EBITDA more than doubling, with margins ex...
- Laurus Labs shares zoom 19% to hit new all-time high. Is there more heat left?Laurus Labs surged over 19% in 11 days, hitting a record high of Rs 799.4. Analysts see strong bullish momentum supported by a multi-year b...
- US foreign aid ban hits HIV-related local drug stocksLaurus Labs slumped 11.6%, Aurobindo declined 2%, Cipla fell 1.1% and Strides dropped 5%. Other pharma shares also declined with 19 out of ...
- Laurus Labs shares nosedive 15% amid reports of US foreign aid suspensionLaurus Labs reported a 7% YoY drop in API revenues to Rs 531 crore for Q3 FY24, driven by lower ARV volumes. However, the FDF segment saw A...
- Stocks in news: Ultratech, Paytm, L&T, Biocon, Alembic PharmaLarsen and Toubro (L&T) has overturned a Rs 702 crore customs duty demand following a favourable ruling from the Central Excise & Service T...
- Stock Radar: Pharma stocks in focus! Laurus Labs looking attractive after 10% fall from 52-week highLaurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity for short-term...
- Stock Radar: Laurus Labs likely to find support above lower band of rectangular pattern; time to buy?Laurus Labs Ltd stock dropped by over 10% from its peak in July 2024 but found support above the 200-day EMA. Experts predicted a potential...
- Buy Laurus Labs, target price Rs 480: Motilal OswalLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 23412.68 Crore) operating in Pharmaceutica...
- Laurus Labs shares hit 10% lower circuit on week Q2 earningsThe pharma company reported a consolidated net profit of Rs 37 crore, which was down by Rs 84% year-on-year versus Rs 233.39 crore posted b...
- Laurus Labs Q3 results: Net profit drops 44% YoY to Rs 154 croreThe earnings before interest, tax, depreciation and amortization (EBITDA) decreased 17% YoY to Rs 290 crore. The EBITDA margins dropped by ...
- Up 341% YTD, this midcap pharma stock has just got more attractiveKotak Securities said the acquisition of Richmore would be value accretive for the company, though the incoming revenue is small to impact ...
- Laurus Labs jumps 4% on acquisition of Richcore LifesciencesThe stock has rallied 10 per cent over the last one week, and has jumped more than 300 per cent year-to-date.
Load More
